Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

Imfinzi 500 mg/10 mL injection Images

Generic Name: durvalumab

This medication has been identified as Imfinzi 500 mg/10 mL injection. It is supplied by AstraZeneca.

Imfinzi is used in the treatment of Non-Small Cell Lung Cancer; Biliary Tract Tumor; Small Cell Lung Cancer and belongs to the drug class anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors). Imfinzi 500 mg/10 mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images

Imfinzi (Durvalumab [ dur-val-ue-mab ])-medicine-500 mg/10 mL injection

Imfinzi
Generic Name: durvalumab [ dur-val-ue-mab ]
Imprint: medicine
Strength: 500 mg/10 mL injection
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00310-4611
Inactive Ingredients:
Latest News
Related Drugs